InMed Announces Update on Biosynthesis Project
VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 02/16/16 -- InMed Pharmaceuticals Inc. ("InMed" or "the Company") (CSE: IN)(OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid- …